p53, K-ras, c-kit and β-catenin gene mutations in sinonasal NK/T-cell lymphoma in Korea and Japan

Oncology Reports

Volumn 13, Issue 2, 2005, Pages 265-271

  Hongyo, Tadashi ^a   Hoshida, Yoshihiko ^a   Nakatsuka, Shin Ichi ^a   Syaifudin, Mukh ^a   Kojya, Shizuo ^b   Yang, Woo Ick ^c   Min, Yoo Hong ^c   Chan, Heekyung ^d   Kim, Chan Hwan ^e   Harabuchi, Yasuaki ^f   Himi, Tetsuo ^g   Inuyama, Masao ^h   Aozasa, Katsuyuki ^a   Nomura, Taisei ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

^c Yonsei University College of Medicine   (South Korea)

^d Kosin University   (South Korea)

^e Inje University College of Medicine   (South Korea)

^f ASAHIKAWA MEDICAL COLLEGE   (Japan)

^g SAPPORO MEDICAL UNIVERSITY   (Japan)

^h HOKKAIDO UNIVERSITY   (Japan)

Author keywords

catenin; c kit; K ras; Mutations; Nasal cavity; NK T cell lymphoma; p53

Indexed keywords

BETA CATENIN; CTNNB1 PROTEIN, HUMAN; CYTOSKELETON PROTEIN; STEM CELL FACTOR RECEPTOR; TRANSACTIVATOR PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; FEMALE; GENETICS; HUMAN; JAPAN; KOREA; MALE; MIDDLE AGED; MIDLINE GRANULOMA; MUTATION; NATURAL KILLER CELL; ONCOGENE RAS; PARANASAL SINUS TUMOR; T CELL LYMPHOMA; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; AGED; BETA CATENIN; CHILD; CYTOSKELETAL PROTEINS; FEMALE; GENES, P53; GENES, RAS; GRANULOMA, LETHAL MIDLINE; HUMANS; JAPAN; KILLER CELLS, NATURAL; KOREA; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; MUTATION; PARANASAL SINUS NEOPLASMS; PROTO-ONCOGENE PROTEINS C-KIT; TRANS-ACTIVATORS;

EID: 16244400830     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Jaffe ES, Chan JKC, Su I-J, et al: Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphoma. Definitions, differential diagnosis, and epidemiology. Am J Surg Pathol 20: 103-111, 1996.
2. Aozasa K, Ohsawa M, Tajima K, et al: Nation-wide study of lethal midline granuloma in Japan: frequencies of Wegener's granulomatosis, polymorphic reticulosis, malignant lymphoma and other related conditions. Int J Cancer 44: 63-66, 1989. (Pubitemid 19184678)
3. Aozasa K, Yang W-I, Lee Y-B, et al: Lethal midline granuloma in Seoul (Korea) and Shanghai (China). Int J Cancer 52: 673-674, 1992.
4. Harabuchi Y, Yamanaka N, Kataura A, et al: Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 335: 128-130, 1990. (Pubitemid 20032725)
5. Tomita Y, Ohsawa M, Mishiro Y, et al: The presence and subtype of Epstein-Barr virus in B- and T-cell lymphomas of the sinonasal region from the Osaka and Okinawa districts of Japan. Lab Invest 73: 190-196, 1995.
6. Li T, Hongyo T, Syaifudin M, et al: Mutations of p53 in nasal NK/T-cell lymphoma. Lab Invest 80: 493-499, 2000. (Pubitemid 30226631)
7. Hongyo T, Li T, Syaifudin M, et al: Specific c-kit mutations in sinonasal NK/T-cell lymphoma in China and Japan. Cancer Res 60: 2345-2347, 2000. (Pubitemid 30262418)
8. Levine AJ, Momand J and Finley CA: The p53 tumor suppressor gene. Nature 351: 453-456, 1991.
9. Hollstein M, Sidransky D, Vogelstein B and Harris CC: p53 mutations in human cancers. Science 253: 49-53, 1991. (Pubitemid 21917115)
10. Donehower LA, Harvey M, Slagle B, et al: Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 356: 215-221, 1992.
11. Huizinga JD, Thuneberg L, Kluppel M, Malysz J, Mikkelsen HB and Bernstein A: W/kit gene required for interstitial cells of Cajal and intestinal pacemaker activity. Nature 373: 347-349, 1995.
12. Barbacid M: Ras oncogenes: their role in neoplasia. Eur J Clin Invest 20: 225-235, 1990.
13. Neri A, Knowles DM, Greco A, McCormick F and Dalla-Favera R: Analysis of RAS oncogene mutations in human lymphoid malignancies. Proc Natl Acad Sci USA 85: 9268-9272, 1998.
14. Aberle H, Butz S, Stappert J, Weissig H, Kemier R and Hoschuetzky H: Assembly of the cadherin-catenin complex in vitro with recombinant proteins. J Cell Sci 12: 3655-3663, 1994.
15. Rubinleld B, Robbins P, El-Gamil M, Albert I, Porfiri E and Polakis P: Stabilization of β-catenin by genetic defects in melanoma cell lines. Science 275: 1790-1792, 1997. (Pubitemid 27136716)
16. He TC, Sparks AB, Rago C, et al: Identification of c-myc as a target of the APC pathway. Science 281: 1509-1512, 1998. (Pubitemid 28425575)
17. Sparks AB, Morin PJ, Vogelstein B and Kinzler KW: Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer. Cancer Res 58: 1130-1134, 1998. (Pubitemid 28183198)
18. Fukuchi T, Sakamoto M, Tsuda H, Maruyama K, Nozawa S and Hirohashi S: B-catenin mutation in carcinoma of the uterine endometrium. Cancer Res 58: 3526-3528, 1998. (Pubitemid 28376543)
19. Hsu H-C, Jeng Y-M, Mao T-L, Chu J-S, Lai P-L and Peng S-Y: β-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis. Am J Pathol 157: 763-770, 2000. (Pubitemid 32109369)
20. Knowles DM, Cesarman E, Chadburn A, et al: Correlative morphologic and molecular genetic analysis demonstrate three distinct categories of posttransplantation lymphoproliferative disorders. Blood 85: 552-565, 1995.
21. Weiss LM, Chen YY, Liu XF and Shibata D: Epstein-Barr virus and Hodgkin's disease: a correlative in situ hybridization and polymerase-chain-reaction study. Am J Pathol 139: 1259-1265, 1991.
22. Hongyo T, Buzard GS, Calvert RJ and Weghorst CM: 'Cold SSCP': a simple, rapid and non-radioactive method for optimized single strand conformation polymorphism analyses. Nucleic Acids Res 21: 3637-3642, 1993. (Pubitemid 23254478)
23. Lipford EHJ, Margolick JB, Longo DL, Fauci AS and Jaffe ES: Angiocentric lymphoproliferative lesions: a clinicopathologic spectrum of post-thymic T-cell proliferations. Blood 72: 1674-1681, 1988. (Pubitemid 18268652)
24. Walker KK and Levine AJ: Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc Natl Acad Sci USA 93: 15335-15340, 1996. (Pubitemid 27009601)
25. Greenblatt MS, Benett WP, Hollstein M and Harris CC: Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855-4878, 1994. (Pubitemid 24289415)
26. Ko YH, Choi KE, Han JH, Kim JM and Ree HJ: Comparative genomic hybridization study of nasal-type NK/T-cell lymphoma. Cytometry 46: 85-91, 2001. (Pubitemid 32423458)
27. Hollstein M, Sidransky D, Vogelestin B and Harris SR: p53 mutations in human cancers. Science 253: 49-53, 1991. (Pubitemid 21917115)
28. Nedergaard T, Guldberg P, Ralfkiaer E and Reuthen J: A one-step DGGE scanning method for detection of mutations in the K-, N-, and H-ras oncogenes: mutations at codons 12, 13 and 61 are rare in B-cell non-Hodgkin's lymphoma. Int J Cancer 71: 364-369, 1997. (Pubitemid 27224298)
29. Nagata H, Worobec AS, Oh CK, et al: Identification of a point mulation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci USA 92: 10560-10564, 1995.
30. Furitsu T, Tsujimura T, Tono T, et al: Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest 92: 1736-1744, 1993. (Pubitemid 23304537)
31. Abrahamson JL, Lee JM and Bernstein A: Regulation of p53-mediated apoptosis and cell cycle arrest by steel factor. Mol Cell Biol 15: 6953-6960, 1995.
32. Kojya S, Matsumura J, Li T, et al: Familial nasal NK/T-cell lymphoma and pesticide use. Am J Hematol 66: 145-147, 2001. (Pubitemid 32096631)